NFKB1 and primary cutaneous T-cell non-Hodgkin lymphoma: The striking recurrence of mutations modifying the TCR/NF-κB pathway highlights its importance in PTCLs including ATL (38, 39, 56–58) and CTCL or Sezary syndrome (43–46, 59–61, 92, 93).